Abdominal circumference should not be a required criterion for the diagnosis of metabolic syndrome

Environmental Health and Preventive Medicine

Volumn 15, Issue 4, 2010, Pages 229-235

  Shibata, Kiyoshi ^a,b   Suzuki, Sadao ^b   Sato, Juichi ^c   Ohsawa, Isao ^d   Goto, Shinichi ^e   Hashiguchi, Masaru ^a   Tokudome, Shinkan ^b,f  

^a Kasugai City Medical Center   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d AICHI GAKUIN UNIVERSITY   (Japan)

^e Kasugai Municipal Hospital   (Japan)

^f NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Central obesity; Diagnostic criteria; Metabolic syndrome; ROC curve

Indexed keywords

ABDOMINAL OBESITY; ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; REFERENCE VALUE; SEX DIFFERENCE; TREND STUDY; WAIST CIRCUMFERENCE;

EID: 77956483702     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-009-0132-7     Document Type: Article

References (27)

1. Matsuzawa Y. Definition and history of metabolic syndrome (in Japanese). Nippon Rinsho. 2006;64:9-12.
2. Wlodarczyk A, Strojek K. Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. Obesity predicts coronary atherosclerosis and dysglycemia. Pol Arch Med Wewn. 2008;118:719-26.
3. Bulugahapitiya U, Siyambalapitiya S, Sithole J, et al. The clinical impact of identifying metabolic syndrome in patients with dia¬betes: a cross-sectional study. Diab Vasc Dis Res. 2009;6:21-4.
4. Ford ES, Schulze MB, Pischon T, et al. Metabolic syndrome and risk of incident diabetes: findings from the European prospective investigation into cancer and nutrition-potsdam study. Cardiovasc Diabetol. 2008;7:35.
5. Wannamethee SG, Shaper AG, Lennon L, et al. Metabolic syn¬drome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644-50.
6. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385-90.
7. Kanauchi M, Kanauchi K, Hashimoto T, et al. Metabolic syn¬drome and new category 'pre-hypertension' in a Japanese popu¬lation. Curr Med Res Opin. 2004;20(9):1365-70.
8. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovas¬cular disease, and all causes in United States adults. Circulation. 2004;110:1245-50.
9. Dart AM, Chin-Dusting JP. Lipids and the endothelium. Car-diovasc Res. 1999;43:308-22.
10. Lindsay RS, Wake DJ, Nair S, et al. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messen¬ger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 2003;88:2738-44.
11. Itoh H. What is 'metabolic domino effectnew concept in lifestyle-related disease (in Japanese). Nippon Rinsho. 2003; 61:1837-43.
12. Itoh H. Metabolic domino: new concept in lifestyle medicine. Drugs Today. 2006;42:9-16.
13. World Health Organization. Definition, diagnosis classification of diabetes mellitus, its complications. Part 1: Diagnosis and clas¬sification of diabetes mellitus. Geneva: World Health Organiza¬tion; 1999.
14. Expert panel on detection, evaluation, treatment of high blood cholesterol in adults. Executive summary of the third report of national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA. 2001;285:2486-97.
15. Alberti KG, Zimmet P, Shaw J. International diabetes federation: a consensus on Type 2 diabetes prevention. Diabetes Med. 2007;24:451-63.
16. The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome (in Japanese). J Jpn Soc Intern Med. 2005;94:794-809.
17. Taylor KJ, Carpenter DA, Hill CR, et al. Gray scale ultrasound imaging. The anatomy and pathology of the liver. Radiology. 1976;119:415-23.
18. Joseph AE, Dewbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the bright liver). Br J Radiol. 1979;52:184-8.
19. Kurtz AB, Dubbins PA, Rubin CS, et al. Echogenicity: analysis, significance, and masking. Am J Roentgenol. 1981;137:471-6.
20. Yajima Y, Ohta K, Narui T, et al. Ultrasound in the diagnosis of diffuse liver disease (in Japanese). Rinsho Hoshasen. 1982;27:553-7.
21. Oda E, Abe M, Veeraveedu PT, et al. Considerable disagreement among definitions of metabolic syndrome for Japanese. Circ J. 2007;71:1239-43.
22. Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract. 2008;79:474-81.
23. Baik I. Optimal cutoff points of waist circumference for the criteria of abdominal obesity: comparison with the criteria of the International Diabetes Federation. Circ J. 2009;73:2068-75.
24. Sato A, Asayama K, Ohkubo T, et al. Optimal cutoff point of waist circumference and use of home blood pressure as a definition of metabolic syndrome: the Ohasama study. Am J Hypertens. 2008;21:514-20.
25. Hara K, Matsushita Y, Horikoshi M, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syn¬drome in the Japanese population. Diabetes Care. 2006;29:1123-4.
26. Kadota A, Hozawa A, Okamura T, et al. NIPPON DATA Research Group. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care. 2007;30:1533-8.
27. Doi Y, Ninomiya T, Hata J, et al. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study. Stroke. 2009;40:1187-94.